Aurora Spine Corp

Aurora Spine Corp has a debt-to-equity ratio of 0.93, indicating a moderate reliance on debt financing relative to equity. The company holds $896,710 in cash and equivalents, but its long-term debt of $3,539,880 exceeds its cash reserves, resulting in a net cash position of -$2,643,170. This suggests potential liquidity constraints, particularly if the company requires additional capital for operations or growth initiatives. Profitability metrics show Aurora Spine Corp is not currently generating positive returns. The company reported a net loss per share of -$0.39 in the latest period, and its revenue of $18,368,030 is below the industry median for comparable medical equipment firms. The company's operating margin and return on invested capital (ROIC) are not disclosed, but the negative earnings and high debt load suggest limited profitability and returns on capital. The company's revenue is concentrated in a single business line focused on spinal implant technologies, with no disclosed geographic diversification. This lack of diversification increases exposure to market-specific risks, such as regulatory changes or shifts in surgical procedure volumes in the spine implant sector. Aurora Spine Corp's growth trajectory is uncertain. The company reported $18,368,030 in revenue for the latest period, but the absence of prior-year data prevents a year-over-year growth assessment. Analysts have recorded a recent actual revenue of $2,861,000, which is significantly lower than the full-year revenue, suggesting potential seasonality or operational volatility. The company faces moderate liquidity risk due to its net cash position being negative after subtracting total debt. While dilution risk is currently low, the company's capital structure includes $3,539,880 in long-term debt, which could necessitate future equity or debt financing. No recent dilutive events are disclosed, but the company's capital expenditure of -$543,610 indicates asset disposals or reductions in capital spending. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's financial snapshot indicates a need for continued monitoring of liquidity and capital structure as it navigates the competitive spinal implant market.